Sharjah, United Arab Emirates — June 4, 2018 — Al Qasimi Hospital in the United Arab Emirates is poised to make history when its surgeons become the first in the country to implant the SynCardia temporary Total Artificial Heart (TAH). The device will be used as a treatment for patients suffering from end-stage heart failure affecting both sides of the heart (biventricular failure).
According to Dr. Arif Al Nooryani, CEO and head of cardiology at Al Qasimi, the SynCardia TAH will help save the lives of patients who would otherwise be out of options. “There are certain complexes for ‘global heart failure’ patients, one of which is waiting time, and sometimes it takes a year or even two years waiting for a suitable heart,” he explains. “These patients are the candidates for the Total Artificial Heart (TAH), which works as a ‘bridging strategy’ for those waiting for a donor heart.”
Dr. Al Nooryani believes the procedure will play a vital role in the fight against heart failure, especially as heart disease cases continue to rise globally. “This is a major disease,” he says. “We should help improve the quality of the patients’ lives. We shouldn’t keep this kind of technology away from them.”
The hospital plans to perform its first TAH implant this year.
Read the full story on the Khaleej Times.